India · Delayed Price · Currency is INR AstraZeneca Pharma India Statistics
Total Valuation
NSE:ASTRAZEN has a market cap or net worth of INR 164.64 billion. The enterprise value is 159.85 billion.
| Market Cap | 164.64B |
| Enterprise Value | 159.85B |
Important Dates
The next estimated earnings date is Friday, February 5, 2027.
| Earnings Date | Feb 5, 2027 |
| Ex-Dividend Date | Jul 31, 2026 |
Share Statistics
| Current Share Class | 25.00M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 6.18% |
| Owned by Institutions (%) | 9.13% |
| Float | 4.61M |
Valuation Ratios
The trailing PE ratio is 92.67.
| PE Ratio | 92.67 |
| Forward PE | n/a |
| PS Ratio | 6.32 |
| PB Ratio | 18.72 |
| P/TBV Ratio | 18.72 |
| P/FCF Ratio | 61.82 |
| P/OCF Ratio | 58.14 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 63.92, with an EV/FCF ratio of 60.02.
| EV / Earnings | 89.87 |
| EV / Sales | 6.14 |
| EV / EBITDA | 63.92 |
| EV / EBIT | 69.29 |
| EV / FCF | 60.02 |
Financial Position
The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.11.
| Current Ratio | 1.63 |
| Quick Ratio | 0.72 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.39 |
| Debt / FCF | 0.36 |
| Interest Coverage | 33.22 |
Financial Efficiency
Return on equity (ROE) is 21.18% and return on invested capital (ROIC) is 36.98%.
| Return on Equity (ROE) | 21.18% |
| Return on Assets (ROA) | 7.57% |
| Return on Invested Capital (ROIC) | 36.98% |
| Return on Capital Employed (ROCE) | 23.01% |
| Weighted Average Cost of Capital (WACC) | 5.46% |
| Revenue Per Employee | 34.24M |
| Profits Per Employee | 2.34M |
| Employee Count | 600 |
| Asset Turnover | 1.37 |
| Inventory Turnover | 1.86 |
Taxes
In the past 12 months, NSE:ASTRAZEN has paid 661.90 million in taxes.
| Income Tax | 661.90M |
| Effective Tax Rate | 27.14% |
Stock Price Statistics
The stock price has decreased by -27.47% in the last 52 weeks. The beta is 0.22, so NSE:ASTRAZEN's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | -27.47% |
| 50-Day Moving Average | 6,381.77 |
| 200-Day Moving Average | 7,845.86 |
| Relative Strength Index (RSI) | 64.69 |
| Average Volume (20 Days) | 10,407 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ASTRAZEN had revenue of INR 26.02 billion and earned 1.78 billion in profits. Earnings per share was 71.09.
| Revenue | 26.02B |
| Gross Profit | 9.16B |
| Operating Income | 2.31B |
| Pretax Income | 2.44B |
| Net Income | 1.78B |
| EBITDA | 2.39B |
| EBIT | 2.31B |
| Earnings Per Share (EPS) | 71.09 |
Balance Sheet
The company has 5.75 billion in cash and 962.10 million in debt, with a net cash position of 4.79 billion.
| Cash & Cash Equivalents | 5.75B |
| Total Debt | 962.10M |
| Net Cash | 4.79B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 8.79B |
| Book Value Per Share | 351.54 |
| Working Capital | 7.51B |
Cash Flow
In the last 12 months, operating cash flow was 2.83 billion and capital expenditures -168.60 million, giving a free cash flow of 2.66 billion.
| Operating Cash Flow | 2.83B |
| Capital Expenditures | -168.60M |
| Depreciation & Amortization | 83.60M |
| Net Borrowing | -112.40M |
| Free Cash Flow | 2.66B |
| FCF Per Share | n/a |
Margins
Gross margin is 35.21%, with operating and profit margins of 8.86% and 6.83%.
| Gross Margin | 35.21% |
| Operating Margin | 8.86% |
| Pretax Margin | 9.37% |
| Profit Margin | 6.83% |
| EBITDA Margin | 9.18% |
| EBIT Margin | 8.86% |
| FCF Margin | 10.20% |
Dividends & Yields
This stock pays an annual dividend of 36.00, which amounts to a dividend yield of 0.55%.
| Dividend Per Share | 36.00 |
| Dividend Yield | 0.55% |
| Dividend Growth (YoY) | 12.50% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 50.64% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.03% |
| Shareholder Yield | 0.51% |
| Earnings Yield | 1.08% |
| FCF Yield | 1.62% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |